Fulgent Genetics, Inc. (FLGT)
Across 22 earnings reports since May 06, 2021, Fulgent Genetics, Inc. (FLGT) has a clear post-earnings pattern. It moves ±9.27% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +19.07% (May 02, 2025) and its largest decline was -38.09% (Feb 27, 2026). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How FLGT moved on each past earnings report.
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±9.27%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 30, 2026 | ☽ POST | -18.1% | open_in_new |
| May 01, 2026 | ☀ PRE | -6.88% | open_in_new |
| Feb 27, 2026 | ☀ PRE | -38.09% | open_in_new |
| Nov 07, 2025 | ☀ PRE | +18.15% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±9.27%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 144 | 20260902 | open_in_new SEC.gov |
| 144 | 20260902 | open_in_new SEC.gov |
| 4 | 20260828 | open_in_new SEC.gov |
| 4 | 20260828 | open_in_new SEC.gov |
| 4 | 20260828 | open_in_new SEC.gov |
| 4 | 20260828 | open_in_new SEC.gov |
Frequently asked about FLGT earnings
When does Fulgent Genetics, Inc. report earnings next? expand_more
Fulgent Genetics, Inc. (FLGT)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does FLGT stock move after earnings? expand_more
Over 22 reports, FLGT has moved an average of ±9.27% the session after earnings, closing higher 50.0% of the time.
What was FLGT's biggest post-earnings move? expand_more
FLGT's largest post-earnings gain on record was +19.07% on May 02, 2025, and its largest decline was -38.09% on Feb 27, 2026.
Where can I find Fulgent Genetics, Inc.'s SEC filings? expand_more
All of Fulgent Genetics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-11-05
- Allegiant Travel CO (ALGT) earnings 2026-11-03
- Alight, Inc. / Delaware (ALIT) earnings 2026-11-06
- Airbnb (ABNB) earnings 2026-11-05
- Abacus Global Management, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABXL) earnings 2026-11-06
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-11-04
- ProFrac Holding Corp. (ACDC) earnings 2026-11-06
- Accel Entertainment, Inc. (ACEL) earnings 2026-11-06